VBI Vaccines Announces Positive Final Phase 1 Study Results of Preventative CMV Vaccine
10 mai 2018 07h30 HE
|
VBI Vaccines, Inc.
CMV neutralizing antibodies against fibroblast cell infection induced in 100% of subjects who received the highest doseSafe and well-tolerated at all doses with no safety signals observedConference...